ELDN
Eledon Pharmaceuticals, Inc.
Company overview
- Market capitalization
- $214.53M
- Employees
- 33
- Latest publication
- 2026-09-29
About Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It uses its immunology expertise in targeting the CD40 Ligand (CD40L) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an IgG1 and anti-CD40L antibody with high affinity for CD40 Ligand, a biological target with therapeutic potential. It is also developing its products for the prevention of allograft rejection in kidney transplantation and xenotransplantation. The company has a collaboration agreement with eGenesis, Inc.; and a strategic collaboration with NewcelX Ltd. for the development of the NCEL-101 therapy for Type 1 Diabetes. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Research Development | 18,230,000USD | 17,197,000USD | 17,491,000USD | 14,969,000USD | 20,276,000USD | 13,531,000USD | 17,928,000USD | 16,520,000USD |
| Total Operating Expenses | 22,869,000USD | 21,181,000USD | 21,484,000USD | 19,070,000USD | 24,733,000USD | 17,964,000USD | 24,696,000USD | 20,510,000USD |
| Net Income | -31,630,000USD | -39,025,000USD | -10,447,000USD | -17,459,000USD | -11,216,000USD | -6,495,000USD | -44,617,000USD | 76,971,000USD |
| Total Revenue | — | 0USD | 0USD | 0USD | 0USD | 0USD | 384,000USD | 0USD |
| Selling General Administrative | — | 3,984,000USD | 3,993,000USD | 4,101,000USD | 4,457,000USD | 4,433,000USD | 6,768,000USD | 3,990,000USD |
| Operating Income | — | -21,181,000USD | -21,484,000USD | -19,070,000USD | -24,733,000USD | -17,964,000USD | -24,696,000USD | -20,510,000USD |
| Income Before Tax | — | -39,025,000USD | -10,412,000USD | -17,459,000USD | -11,216,000USD | -6,495,000USD | -44,186,000USD | 76,971,000USD |
| Net Income From Continuing Ops | — | -39,025,000USD | -10,447,000USD | -17,459,000USD | -11,216,000USD | -6,495,000USD | -44,617,000USD | 76,971,000USD |
| Ebitda | — | -21,181,000USD | -21,403,000USD | -19,070,000USD | -24,733,000USD | -17,964,000USD | -24,608,000USD | -20,510,000USD |
| Total Other Income Expense Net | — | -17,844,000USD | 11,072,000USD | 1,611,000USD | 13,517,000USD | 11,469,000USD | -19,490,000USD | 97,481,000USD |
| Income Tax Expense | — | — | 35,000USD | — | — | — | 431,000USD | — |
| Ebit | — | — | -21,484,000USD | — | — | -24,458,999USD | -24,696,000USD | -20,589,000USD |
| Depreciation And Amortization | — | — | 81,000USD | — | — | 17,964,000USD | 88,000USD | 79,000USD |
| Reconciled Depreciation | — | — | 81,000USD | — | — | — | 88,000USD | 79,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | 100,000USD | 95,000USD | 100,000USD |
| Cost Of Revenue | — | — | — | — | — | — | 88,000USD | 79,000USD |
| Gross Profit | — | — | — | — | — | — | -88,000USD | -79,000USD |
| Source | DisclosurePreliminary | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 120,000USD | 120,000USD | 0USD | 0USD |
| Research Development | 66,267,000USD | 51,964,000USD | 30,312,000USD | 27,080,000USD | 23,735,000USD | 6,131,000USD | 8,128,000USD | 6,817,000USD |
| Selling General Administrative | 16,984,000USD | 18,613,000USD | 12,688,000USD | 12,700,000USD | 13,132,000USD | 10,052,000USD | 6,056,000USD | 7,243,000USD |
| Total Operating Expenses | 83,251,000USD | 70,577,000USD | 42,626,000USD | 88,428,000USD | 36,867,000USD | 18,465,000USD | 14,002,000USD | 14,060,000USD |
| Operating Income | -83,251,000USD | -70,577,000USD | -43,000,000USD | -88,428,000USD | -36,867,000USD | -18,465,000USD | -14,184,000USD | -14,060,000USD |
| Income Before Tax | -45,582,000USD | -35,753,000USD | -40,326,000USD | -87,966,000USD | -36,860,000USD | -23,215,000USD | -16,011,000USD | -14,065,000USD |
| Income Tax Expense | 35,000USD | 431,000USD | — | -462,000USD | -2,354,000USD | -404,000USD | 1,867,000USD | -5,000USD |
| Tax Provision | 35,000USD | 431,000USD | 0USD | -579,000USD | -2,354,000USD | -404,000USD | — | — |
| Net Income | -45,617,000USD | -36,184,000USD | -40,326,000USD | -87,966,000USD | -34,506,000USD | -22,811,000USD | -16,011,000USD | -14,065,000USD |
| Net Income From Continuing Ops | -45,617,000USD | -36,184,000USD | -89,084,000USD | -87,966,000USD | -34,506,000USD | -22,811,000USD | -16,011,000USD | -14,065,000USD |
| Ebit | -83,251,000USD | -70,577,000USD | -43,000,000USD | -39,780,000USD | -36,867,000USD | -16,183,000USD | -16,011,000USD | -14,060,000USD |
| Ebitda | -82,938,000USD | -70,218,000USD | -42,626,000USD | -39,407,000USD | -36,672,000USD | -16,000,000USD | -15,829,000USD | -14,049,000USD |
| Depreciation And Amortization | 313,000USD | 359,000USD | 374,000USD | 373,000USD | 195,000USD | 183,000USD | 182,000USD | 11,000USD |
| Reconciled Depreciation | 313,000USD | 359,000USD | 373,000USD | 373,000USD | 195,000USD | 183,000USD | 182,000USD | 11,000USD |
| Total Other Income Expense Net | 37,669,000USD | 34,824,000USD | 2,674,000USD | 462,000USD | 7,000USD | -4,750,000USD | -1,827,000USD | -5,000USD |
| Cost Of Revenue | — | 359,000USD | 374,000USD | 373,000USD | 195,000USD | 183,000USD | 182,000USD | 11,000USD |
| Gross Profit | — | -359,000USD | -374,000USD | -373,000USD | 120,000USD | -183,000USD | -182,000USD | -11,000USD |
| Unclassified Operating Expenses | — | — | — | 48,648,000USD | — | 2,282,000USD | — | — |
| Interest Expense | — | — | — | 462,000USD | 202,000USD | 9,658,000USD | 0USD | 0USD |
| Net Interest Income | — | — | — | — | 0USD | -4,829,000USD | — | — |
| Net Income Applicable To Common Shares | — | — | — | — | -34,506,000USD | -22,811,000USD | -16,011,000USD | -14,065,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 126,094,000USD | 146,667,000USD | 169,009,000USD | 129,857,000USD | 144,909,000USD | 161,308,000USD | 177,405,000USD | 114,576,000USD |
| Cash And Equivalents | 6,803,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 88,756,000USD | 111,089,000USD | 133,336,000USD | 93,401,000USD | 107,570,000USD | 124,881,000USD | 140,178,000USD | 78,191,000USD |
| Short Term Investments | 81,953,000USD | 104,937,000USD | 110,528,000USD | 89,732,000USD | 101,829,000USD | 116,385,000USD | 119,629,000USD | 71,440,000USD |
| Total Current Assets | 93,091,000USD | 113,574,000USD | 135,688,000USD | 96,301,000USD | 111,404,000USD | 127,718,000USD | 143,730,000USD | 81,509,000USD |
| Other Current Assets | 382,000USD | 1,902,000USD | 1,838,000USD | 2,147,000USD | 3,129,000USD | 2,076,000USD | 3,552,000USD | 3,318,000USD |
| Other Non Current Assets | 172,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 54,063,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 11,789,000USD | 13,458,000USD | 18,344,000USD | 14,296,000USD | 13,719,000USD | 9,185,000USD | 11,577,000USD | 12,489,000USD |
| Total Stockholder Equity | 33,013,000USD | 100,458,000USD | 81,085,000USD | 35,360,000USD | 106,028,000USD | 114,580,000USD | 118,140,000USD | 76,058,000USD |
| Total Equity Including Noncontrolling Interest | 72,031,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 445,000USD | 530,000USD | 613,000USD | 694,000USD | 773,000USD | 850,000USD | 926,000USD | 471,000USD |
| Accounts Payable | 3,214,000USD | 6,585,000USD | 3,627,000USD | 4,627,000USD | 5,831,000USD | 2,901,000USD | 5,833,000USD | 5,860,000USD |
| Short Term Debt | 381,000USD | 369,000USD | 358,000USD | 346,000USD | 336,000USD | 325,000USD | 314,000USD | 186,000USD |
| Common Stock | 81,000USD | 76,000USD | 75,000USD | 60,000USD | 60,000USD | 60,000USD | 60,000USD | 41,000USD |
| Retained Earnings | -471,858,000USD | -440,228,000USD | -401,203,000USD | -390,756,000USD | -373,297,000USD | -362,081,000USD | -355,586,000USD | -310,969,000USD |
| Accumulated Other Comprehensive Income | -114,000USD | -72,000USD | 24,000USD | 9,000USD | -48,000USD | -18,000USD | 26,000USD | 102,000USD |
| Intangible Assets | — | 32,386,000USD | 32,386,000USD | 32,386,000USD | 32,386,000USD | 32,386,000USD | 32,386,000USD | 32,386,000USD |
| Total Liab | — | 46,209,000USD | 87,924,000USD | 94,497,000USD | 38,881,000USD | 46,728,000USD | 59,265,000USD | 38,518,000USD |
| Other Current Liab | — | 6,504,000USD | 14,359,000USD | 9,323,000USD | 7,552,000USD | 5,959,000USD | 5,430,000USD | 6,443,000USD |
| Capital Stock | — | 76,000USD | 75,000USD | 60,000USD | 60,000USD | 60,000USD | 60,000USD | 41,000USD |
| Cash | — | 6,152,000USD | 22,808,000USD | 3,669,000USD | 5,741,000USD | 8,496,000USD | 20,549,000USD | 6,751,000USD |
| Net Debt | — | -5,597,000USD | -22,167,000USD | -2,947,000USD | -4,938,000USD | -7,616,000USD | -19,595,000USD | -6,250,000USD |
| Short Long Term Debt Total | — | 555,000USD | 641,000USD | 722,000USD | 803,000USD | 880,000USD | 954,000USD | 501,000USD |
| Net Receivables | — | 583,000USD | 514,000USD | 753,000USD | 705,000USD | 761,000USD | — | — |
| Property Plant Equipment Gross | — | 530,000USD | 613,000USD | 694,000USD | 773,000USD | 850,000USD | 926,000USD | 471,000USD |
| Common Stock Shares Outstanding | — | 112,424,211shares | 75,430,033shares | 77,156,068shares | 77,156,068shares | 77,126,763shares | 59,789,275shares | 55,478,342shares |
| Non Current Assets Total | — | 33,093,000USD | 33,321,000USD | 33,556,000USD | 33,505,000USD | 33,590,000USD | 33,675,000USD | 33,067,000USD |
| Non Current Liabilities Total | — | 32,751,000USD | 69,580,000USD | 80,201,000USD | 25,162,000USD | 37,543,000USD | 47,688,000USD | 26,029,000USD |
| Non Currrent Assets Other | — | 177,000USD | 322,000USD | 476,000USD | 346,000USD | 354,000USD | 363,000USD | 210,000USD |
| Net Working Capital | — | 100,116,000USD | 117,344,000USD | 82,005,000USD | 97,685,000USD | 118,533,000USD | 132,153,000USD | 69,020,000USD |
| Unclassified Non Current Liabilities | — | 32,751,000USD | 69,580,000USD | 80,201,000USD | 25,162,000USD | 37,543,000USD | 47,688,000USD | 26,029,000USD |
| Unclassified Equity | — | 540,606,000USD | 482,114,000USD | 425,987,000USD | 479,253,000USD | 476,559,000USD | 473,580,000USD | 386,843,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 169,009,000USD | 177,405,000USD | 125,894,000USD | 92,793,000USD | 170,548,000USD | 197,185,000USD | 10,931,000USD | 17,026,000USD |
| Intangible Assets | 32,386,000USD | 32,386,000USD | 32,386,000USD | 32,386,000USD | 32,386,000USD | 32,386,000USD | — | — |
| Other Current Assets | 1,838,000USD | 3,552,000USD | 5,027,000USD | 3,109,000USD | 3,513,000USD | 1,325,000USD | 54,000USD | 710,000USD |
| Total Liab | 87,924,000USD | 59,265,000USD | 42,475,000USD | 8,610,000USD | 6,553,000USD | 6,589,000USD | 1,466,000USD | 2,534,000USD |
| Total Stockholder Equity | 81,085,000USD | 118,140,000USD | 83,419,000USD | 84,183,000USD | 163,995,000USD | 190,596,000USD | 9,465,000USD | 14,492,000USD |
| Other Current Liab | 14,359,000USD | 5,430,000USD | 2,545,000USD | 3,912,000USD | 2,219,000USD | 973,000USD | 813,000USD | 1,845,000USD |
| Common Stock | 75,000USD | 60,000USD | 24,000USD | 14,000USD | 14,000USD | 15,000USD | 13,000USD | 9,000USD |
| Capital Stock | 75,000USD | 60,000USD | 24,000USD | 14,000USD | 14,000USD | 15,000USD | 13,000USD | 9,000USD |
| Retained Earnings | -401,203,000USD | -355,586,000USD | -243,191,000USD | -202,865,000USD | -114,899,000USD | -80,393,000USD | -57,582,000USD | -41,571,000USD |
| Cash | 22,808,000USD | 20,549,000USD | 4,612,000USD | 56,409,000USD | 84,833,000USD | 114,195,000USD | 8,791,000USD | 12,972,000USD |
| Cash And Short Term Investments | 133,336,000USD | 140,178,000USD | 51,102,000USD | 56,409,000USD | 84,833,000USD | 114,195,000USD | 8,791,000USD | 12,972,000USD |
| Total Current Assets | 135,688,000USD | 143,730,000USD | 56,129,000USD | 59,518,000USD | 88,346,000USD | 115,630,000USD | 9,971,000USD | 14,276,000USD |
| Total Current Liabilities | 18,344,000USD | 11,577,000USD | 3,895,000USD | 6,475,000USD | 4,401,000USD | 2,483,000USD | 1,322,000USD | 2,534,000USD |
| Net Debt | -22,167,000USD | -19,595,000USD | -4,229,000USD | -55,663,000USD | -84,064,000USD | -114,051,000USD | -8,467,000USD | -12,972,000USD |
| Short Term Debt | 358,000USD | 314,000USD | 383,000USD | 363,000USD | 369,000USD | 144,000USD | 180,000USD | — |
| Short Long Term Debt Total | 641,000USD | 954,000USD | 383,000USD | 746,000USD | 769,000USD | 144,000USD | 324,000USD | — |
| Short Term Investments | 110,528,000USD | 119,629,000USD | 46,490,000USD | 0USD | — | — | — | — |
| Net Receivables | 514,000USD | — | — | — | — | 110,000USD | 245,000USD | 594,000USD |
| Accounts Payable | 3,627,000USD | 5,833,000USD | 967,000USD | 2,200,000USD | 1,813,000USD | 1,366,000USD | 329,000USD | 689,000USD |
| Property Plant Equipment Net | 613,000USD | 926,000USD | 365,000USD | 739,000USD | 768,000USD | 138,000USD | 321,000USD | 14,000USD |
| Property Plant Equipment Gross | 613,000USD | 926,000USD | 365,000USD | 739,000USD | 768,000USD | 138,000USD | 321,000USD | 14,000USD |
| Accumulated Other Comprehensive Income | 24,000USD | 26,000USD | 0USD | 0USD | — | 0USD | 0USD | — |
| Common Stock Shares Outstanding | 81,836,246shares | 48,543,787shares | 24,619,197shares | 14,285,254shares | 14,819,582shares | 15,160,397shares | 655,525shares | 500,297shares |
| Non Current Assets Total | 33,321,000USD | 33,675,000USD | 69,765,000USD | 33,275,000USD | 82,202,000USD | 81,555,000USD | 960,000USD | 2,750,000USD |
| Non Current Liabilities Total | 69,580,000USD | 47,688,000USD | 38,580,000USD | 2,135,000USD | 2,152,000USD | 4,106,000USD | 144,000USD | 1,845,000USD |
| Non Currrent Assets Other | 322,000USD | 363,000USD | 186,000USD | 150,000USD | 400,000USD | 383,000USD | 639,000USD | 869,000USD |
| Net Working Capital | 117,344,000USD | 132,153,000USD | 52,234,000USD | 53,043,000USD | 83,945,000USD | 113,147,000USD | 8,649,000USD | 11,742,000USD |
| Unclassified Non Current Liabilities | 69,580,000USD | 47,688,000USD | 38,580,000USD | 2,135,000USD | — | — | — | 1,845,000USD |
| Unclassified Equity | 482,114,000USD | 473,580,000USD | 326,562,000USD | 287,020,000USD | 278,866,000USD | 270,959,000USD | 67,021,000USD | 56,045,000USD |
| Unclassified Non Current Assets | — | — | 36,828,000USD | — | — | -32,907,000USD | — | — |
| Good Will | — | — | — | 0USD | 48,648,000USD | 48,648,000USD | 0USD | 1,867,000USD |
| Other Liab | — | — | — | — | 1,752,000USD | 4,106,000USD | — | — |
| Other Assets | — | — | — | — | 400,000USD | 32,907,000USD | 639,000USD | 869,000USD |
| Net Tangible Assets | — | — | — | — | 82,961,000USD | 109,562,000USD | 9,465,000USD | 12,625,000USD |
| Inventory | — | — | — | — | — | 1,287,000USD | 881,000USD | — |
| Unclassified Current Assets | — | — | — | — | — | -1,287,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Change In Working Capital | -1,833,000USD |
| Operating Cash Flow | -45,289,000USD |
| Net Investments | 29,193,000USD |
| Investing Cash Flow | 29,193,000USD |
| Financing Cash Flow | 91,000USD |
| Change In Cash | -16,005,000USD |
| End Cash Flow | 6,803,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -39,025,000USD | -10,447,000USD | -17,459,000USD | -11,216,000USD | -6,495,000USD | -44,617,000USD | 63,635,000USD | -44,907,000USD |
| Stock Based Compensation | 2,202,000USD | 2,465,000USD | 2,428,000USD | 2,694,000USD | 2,864,000USD | 6,582,000USD | 1,783,000USD | 3,063,000USD |
| Other Non Cash Items | 20,787,000USD | -10,772,000USD | -2,265,000USD | -12,648,000USD | -10,676,000USD | 20,046,000USD | -84,068,000USD | 30,813,000USD |
| Change In Working Capital | -4,374,000USD | 4,658,000USD | 2,819,000USD | 3,457,000USD | -1,753,000USD | -1,517,000USD | 6,802,000USD | 3,160,000USD |
| Total Cash From Operating Activities | -22,612,000USD | -14,091,000USD | -14,477,000USD | -17,713,000USD | -16,060,000USD | -18,987,000USD | -11,769,000USD | -7,774,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -22,612,000USD | -14,091,000USD | -14,477,000USD | -17,713,000USD | -16,060,000USD | -18,987,000USD | -11,769,000USD | -7,774,000USD |
| Investments | 5,956,000USD | -20,462,000USD | 12,405,000USD | 14,958,000USD | 3,892,000USD | -47,382,000USD | -12,802,000USD | -19,913,000USD |
| Total Cashflows From Investing Activities | 5,956,000USD | -20,462,000USD | 12,405,000USD | 14,958,000USD | 3,892,000USD | -47,382,000USD | -12,802,000USD | -19,913,000USD |
| Total Cash From Financing Activities | 0USD | 53,692,000USD | 0USD | 0USD | 115,000USD | 80,167,000USD | 5,283,000USD | 48,071,000USD |
| Change In Cash | -16,656,000USD | 19,139,000USD | -2,072,000USD | -2,755,000USD | -12,053,000USD | 13,798,000USD | -19,288,000USD | 20,384,000USD |
| Begin Period Cash Flow | 22,808,000USD | 3,669,000USD | 5,741,000USD | 8,496,000USD | 20,549,000USD | 6,751,000USD | 26,039,000USD | 5,655,000USD |
| End Period Cash Flow | 6,152,000USD | 22,808,000USD | 3,669,000USD | 5,741,000USD | 8,496,000USD | 20,549,000USD | 6,751,000USD | 26,039,000USD |
| Unclassified Operating Cash Flow | -2,202,000USD | — | — | — | — | — | — | — |
| Depreciation | — | 81,000USD | — | — | — | 88,000USD | 79,000USD | 97,000USD |
| Issuance Of Capital Stock | — | 53,577,000USD | 0USD | 0USD | 0USD | 79,952,000USD | 5,283,000USD | 48,071,000USD |
| Other Cashflows From Financing Activities | — | 53,692,000USD | 115,000USD | — | 115,000USD | 215,000USD | -12,802,000USD | -33,017USD |
| Unclassified Financing Cash Flow | — | -53,577,000USD | — | — | — | — | 12,802,000USD | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | 1USD | -1USD | 9,783,000USD |
| Unclassified Investing Cash Flow | — | — | — | — | — | — | — | -9,783,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -45,617,000USD | -36,184,000USD | -40,326,000USD | -87,966,000USD | -34,506,000USD | -22,811,000USD | -16,011,000USD | -14,065,000USD |
| Depreciation | 313,000USD | 359,000USD | 374,000USD | 373,000USD | 195,000USD | 183,000USD | 182,000USD | 11,000USD |
| Stock Based Compensation | 10,451,000USD | 13,122,000USD | 6,545,000USD | 8,153,000USD | 7,904,000USD | 3,171,000USD | 1,308,000USD | 1,543,000USD |
| Other Non Cash Items | -34,832,000USD | -33,709,000USD | 8,690,000USD | 48,648,000USD | 7,904,000USD | 4,829,000USD | 1,867,000USD | 471,000USD |
| Change In Working Capital | 7,652,000USD | 8,710,000USD | -4,917,000USD | 2,368,000USD | -152,000USD | -180,000USD | -1,203,000USD | 618,000USD |
| Total Cash From Operating Activities | -62,341,000USD | -47,271,000USD | -39,527,000USD | -28,424,000USD | -28,913,000USD | -15,212,000USD | -13,857,000USD | -11,893,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -62,341,000USD | -47,271,000USD | -39,527,000USD | -28,424,000USD | -28,913,000USD | -15,212,000USD | -13,857,000USD | -11,893,000USD |
| Investments | 10,793,000USD | -70,314,000USD | -45,287,000USD | 0USD | 0USD | 11,035,000USD | — | 0USD |
| Total Cashflows From Investing Activities | 10,793,000USD | -70,314,000USD | — | — | — | 11,035,000USD | 11,035,000USD | 11,035,000USD |
| Total Cash From Financing Activities | 53,807,000USD | 133,522,000USD | 33,017,000USD | 33,017,000USD | -449,000USD | 109,581,000USD | 9,676,000USD | 7,562,000USD |
| Issuance Of Capital Stock | 53,577,000USD | 133,307,000USD | 33,017,000USD | 0USD | 9,000,000USD | 104,226,000USD | 9,676,000USD | 7,491,000USD |
| Change In Cash | 2,259,000USD | 15,937,000USD | -51,797,000USD | -28,424,000USD | -29,362,000USD | 105,404,000USD | -4,181,000USD | -4,331,000USD |
| Begin Period Cash Flow | 20,549,000USD | 4,612,000USD | 56,409,000USD | 84,833,000USD | 114,195,000USD | 8,791,000USD | 12,972,000USD | 17,303,000USD |
| End Period Cash Flow | 22,808,000USD | 20,549,000USD | 4,612,000USD | 56,409,000USD | 84,833,000USD | 114,195,000USD | 8,791,000USD | 12,972,000USD |
| Other Cashflows From Financing Activities | 53,807,000USD | 215,000USD | 33,017USD | — | -449,000USD | 100,606,000USD | 9,676USD | 71,000USD |
| Unclassified Financing Cash Flow | -53,577,000USD | — | — | 33,017,000USD | -9,000,000USD | 9,000,025USD | — | — |
| Unclassified Operating Cash Flow | — | — | -9,893,000USD | — | -10,258,000USD | — | — | — |
| Change To Liabilities | — | — | — | — | 2,143,000USD | -39,000USD | -1,392,000USD | 1,094,000USD |
| Dividends Paid | — | — | — | — | — | -25,000USD | — | — |
| Sale Purchase Of Stock | — | — | — | — | — | -25USD | — | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | 11,035,000USD | — | — |
| Unclassified Investing Cash Flow | — | — | — | — | — | -11,035,000USD | 11,035,000USD | 11,035,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.